Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11399867rdf:typepubmed:Citationlld:pubmed
pubmed-article:11399867lifeskim:mentionsumls-concept:C0242957lld:lifeskim
pubmed-article:11399867lifeskim:mentionsumls-concept:C0024623lld:lifeskim
pubmed-article:11399867lifeskim:mentionsumls-concept:C0069515lld:lifeskim
pubmed-article:11399867lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:11399867lifeskim:mentionsumls-concept:C0008838lld:lifeskim
pubmed-article:11399867lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:11399867lifeskim:mentionsumls-concept:C1704824lld:lifeskim
pubmed-article:11399867lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:11399867lifeskim:mentionsumls-concept:C2346484lld:lifeskim
pubmed-article:11399867lifeskim:mentionsumls-concept:C1881189lld:lifeskim
pubmed-article:11399867pubmed:issue4lld:pubmed
pubmed-article:11399867pubmed:dateCreated2001-6-11lld:pubmed
pubmed-article:11399867pubmed:abstractTextThe c-erbB-2 oncogene encodes a transmembrane tyrosine kinase receptor and its abnormal expression may be related to the prognosis of gastric cancer. Gastric cancer is relatively resistant to various drugs, including cisplatin. Cisplatin is widely used in cancer chemotherapy, but the mechanisms of drug resistance are not yet known.lld:pubmed
pubmed-article:11399867pubmed:languageenglld:pubmed
pubmed-article:11399867pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11399867pubmed:citationSubsetIMlld:pubmed
pubmed-article:11399867pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11399867pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11399867pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11399867pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11399867pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11399867pubmed:statusMEDLINElld:pubmed
pubmed-article:11399867pubmed:issn0009-3157lld:pubmed
pubmed-article:11399867pubmed:authorpubmed-author:MiuraTTlld:pubmed
pubmed-article:11399867pubmed:authorpubmed-author:KakuMMlld:pubmed
pubmed-article:11399867pubmed:authorpubmed-author:FunatoTTlld:pubmed
pubmed-article:11399867pubmed:authorpubmed-author:KozawaKKlld:pubmed
pubmed-article:11399867pubmed:authorpubmed-author:FujimakiSSlld:pubmed
pubmed-article:11399867pubmed:issnTypePrintlld:pubmed
pubmed-article:11399867pubmed:volume47lld:pubmed
pubmed-article:11399867pubmed:ownerNLMlld:pubmed
pubmed-article:11399867pubmed:authorsCompleteYlld:pubmed
pubmed-article:11399867pubmed:pagination297-303lld:pubmed
pubmed-article:11399867pubmed:dateRevised2009-11-11lld:pubmed
pubmed-article:11399867pubmed:meshHeadingpubmed-meshheading:11399867...lld:pubmed
pubmed-article:11399867pubmed:meshHeadingpubmed-meshheading:11399867...lld:pubmed
pubmed-article:11399867pubmed:meshHeadingpubmed-meshheading:11399867...lld:pubmed
pubmed-article:11399867pubmed:meshHeadingpubmed-meshheading:11399867...lld:pubmed
pubmed-article:11399867pubmed:meshHeadingpubmed-meshheading:11399867...lld:pubmed
pubmed-article:11399867pubmed:meshHeadingpubmed-meshheading:11399867...lld:pubmed
pubmed-article:11399867pubmed:meshHeadingpubmed-meshheading:11399867...lld:pubmed
pubmed-article:11399867pubmed:meshHeadingpubmed-meshheading:11399867...lld:pubmed
pubmed-article:11399867pubmed:meshHeadingpubmed-meshheading:11399867...lld:pubmed
pubmed-article:11399867pubmed:articleTitleIncreased sensitivity to cisplatin in gastric cancer by antisense inhibition of the her-2/neu (c-erbB-2) gene.lld:pubmed
pubmed-article:11399867pubmed:affiliationDivision of Molecular Diagnostics, Department of Clinical Medicine, Tohoku University School of Medicine, Sendai, Japan. tfunato@mail.cc.tohoku.ac.jplld:pubmed
pubmed-article:11399867pubmed:publicationTypeJournal Articlelld:pubmed